Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Where
Chengdu
Age
18 years and over
People
22
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07274852
Phase 1Not yet taking people in China
NK-cell Therapy Combined With PD-1 Antibody and Platinum-Based Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC
Where
Guangzhou
Age
18 years and over
People
10
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07318636
Phase 2/3Not yet taking people in China
A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer
Where
Guangzhou
Age
18 years and over
People
720
Run by
Shanghai Henlius Biotech
See details and how to joinNCT07318883
Phase 4Taking people
Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)
Where
Fuzhou
Age
18 years to 75 years
People
60
Run by
Fujian Cancer Hospital
See details and how to joinNCT07320105
Phase 1/2Taking people
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Where
Zhengzhou
Age
18 years to 75 years
People
54
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT05978284
Phase 1/2Taking people
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
50
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06903377
Phase 1/2Taking people
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
60
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT06938880
Phase 1/2Taking people
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Where
Guanzhou
Age
18 years to 70 years
People
350
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07038096
Phase 2Taking people
Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
Where
Chengdu, Guangzhou
Age
28 years to 75 years
People
115
Run by
Guangdong Association of Clinical Trials
See details and how to joinNCT07120698
Phase 3Taking people
Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
Where
Shanghai
Age
18 years to 75 years
People
420
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07189455
Phase 2Taking people
Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer
Where
Chengdu
Age
18 years to 75 years
People
30
Run by
Sichuan University
See details and how to joinNCT06877299
No phaseTaking people
Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
Where
Shanghai
Age
18 years and over
People
400
Run by
Shanghai Chest Hospital
See details and how to joinNCT07135856
Phase 2Taking people
Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
Where
Xi'an
Age
18 years to 75 years
People
32
Run by
Tang-Du Hospital
See details and how to joinNCT07141264
Phase 2Not yet taking people in China
A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.
Where
Beijing
Age
18 years and over
People
28
Run by
Zhijie Wang
See details and how to joinNCT07307443
Phase 2Not yet taking people in China
Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer
Where
Guangzhou
Age
18 years and over
People
16
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07303881
Phase 2Taking people
Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases
Where
Cangzhou, Tianjin
Age
18 years to 75 years
People
30
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07304739
No phaseTaking people
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
Where
Beijing, Chengdu, Foshan, Guangzhou, Shanghai, Wuhan
Age
18 years to 80 years
People
3,000
Run by
ChromX Health
See details and how to joinNCT06518655
Phase 2Taking people
Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations
Where
Shanghai
Age
18 years and over
People
34
Run by
Fudan University
See details and how to joinNCT07117890
No phaseTaking people
Exploratory Trial of Navigational Bronchoscopy-Guided Cryoablation in Lung Cancer Treatment
Where
Shanghai
Age
18 years to 80 years
People
40 worldwide
Run by
Tianjin Puli Ark Medical Technology Co., Ltd.
See details and how to joinNCT07301411
Phase 1/2Taking people
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Where
Beijing
Age
18 years to 70 years
People
248
Run by
Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06512051
Phase 2Not yet taking people in China
Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC
Where
Guangzhou
Age
18 years and over
People
69
Run by
Sun Yat-sen University
See details and how to joinNCT07294261
Phase 2Taking people
A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Where
Shanghai
Age
18 years to 80 years
People
120
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07003321
Phase 2Taking people
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
Where
Shanghai
Age
18 years to 75 years
People
240
Run by
Shenyang Sunshine Pharmaceutical Co., LTD.
See details and how to joinNCT07171606
Phase 1Taking people
JMT106 Injection in the Treatment of Advanced Solid Tumors
Where
Zhejiang
Age
18 years and over
People
200
Run by
Shanghai JMT-Bio Inc.
See details and how to joinNCT07275073
Phase 2Taking people
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
Where
Chengdu, Chongqing, Guiyang, Nanchong, Wuhan
Age
18 years to 75 years
People
114
Run by
Sichuan University
See details and how to joinNCT06121505